Connect on Social Media
LinkedIn:
Twitter:
Website:
About
First Name:
Last Name:
Title and Organization:
Bio:
James McCarter MD PhD is an experienced executive and researcher with a track-record of success in early-stage life-science technology companies. He currently leads BioGenerator Ventures as Senior Managing Director and is Senior Vice President at BioSTL in St. Louis creating, building, and investing in start-ups that solve important problems in human health and agriculture. Previously, he led clinical research and medical affairs for new biosensors at Abbott Laboratories launching OTC CGM technology in the US and UK. Prior to Abbott, he led research and clinical operations for Virta Health, a tech-enabled nationwide medical provider delivering the first clinically-proven treatment to safely and sustainably reverse type 2 diabetes (T2D). Dr. McCarter directed the Virta clinical trial proving diabetes reversal at scale resulting in changes to the American Diabetes Association 2019 standards of care and creating a paradigm shift in T2D treatment. He is an Adjunct Professor of Genetics at Washington University School of Medicine and was an Entrepreneur in Residence at BioGenerator. Dr. McCarter was the Founder, President, and Chief Scientific Officer of Divergence, Inc., a front-runner in the application of genomics to infectious disease and agriculture. The Company’s discoveries led to products in agriculture and veterinary diagnostics. Divergence was acquired by Monsanto where he was an executive in chemistry technology and with Monsanto Growth Ventures. Dr. McCarter was a scientific advisor for Readout, Inc. and was a board observer for Neurolutions, Inc., both medical device companies supported by BioGenerator. Dr. McCarter completed his undergraduate study in biology at Princeton University, his M.D. and Ph.D. degrees at Washington Univ. and his post-doctoral training at the Washington Univ. Genome Institute, leading an international sequencing consortium. He is the founder of Washington Univ.’s Young Scientist Program providing disadvantaged students access to scientific careers and serves on the School of Medicine National Council. He is an author of over 70 scientific publications and patents and has served on 20 non-profit boards and professional advisory boards including two World Health Organization panels. Dr. McCarter is a recipient of the Innovation Award from the Academy of Science of St. Louis and is a Henry Crown Fellow of the Aspen Institute. He and his wife, also a doctor, have two sons. The family lives in the City of St. Louis and farms in nearby Labadie Missouri.
Fellowship Program
Class
